Martin Stern
Advisor to HBM Partners
Over 25 years of clinical medicine and pharma/biotech experience with a focus on preclinical and early clinical drug development up to proof of concept. MD from the University of Basel; board-certified hematologist. Former Swiss National Science Foundation Professor of Immunology. Previously Translational Medicine Leader at Roche pRED, Chief Medical Officer at Affivant Sciences and Numab Therapeutics.
